ALL >> General >> View Article
With Two Approved Drugs And Close To 300 Clinical / Preclinical Product Candidates, The Bispecific
With various target combinations and novel mechanisms of action, bispecific antibodies are presently recognized as a potent class of targeted therapies, with the potential to be used as treatment options for a variety of disease indications. Several pipeline candidates have recently entered mid to late-stage (phase II and above) trials and are anticipated to enter the market over the next 5-10 years.
To order this 370+ page report, which features 90+ figures and 110+ tables, please visit this link
The USD 6.9 billion financial opportunity (by 2030) within the bispecific antibody therapeutics market has been analyzed across the following segments:
Therapeutic Area
Autoimmune Disorders
Eye Disorders
Genetic Disorders
Hematological Malignancies
Infectious Diseases
Inflammatory Disorders
Skin Disorders
Mechanism of Action
Cytokines Retargeting / Neutralization
Dual Ligands Blocking
T-cell Retargeting / Activation
Others
Target Antigens
CD3 x CD19
CD30 ...
... x CD16A
Factor IXa x Factor X
IL-1α x IL-1β
IL-13 x IL-4
IL-17A x Albumin
IL-17A x IL-17F
Psl x PcrV
VEGF-A x ANG2
Others
Antibody Formats
Asymmetric
Fragments
Symmetric
Others
Key Geographical Regions
North America
Europe
Asia-Pacific
The Bispecific Antibody Therapeutics Market (4th Edition), 2020-2030 report features the following companies, which we identified to be key players in this domain:
Amgen
Ablynx
AbbVie
Affibody
Affimed
Alphamab
AstraZeneca
Avillion
Chugai Pharmaceuticals
Eddingpharm
GSK
Merck
Merus
Roche
Regeneron Pharmaceuticals
Taisho Pharmaceuticals
Zymeworks
Table of Contents
1. Preface
2. Executive Summary
3. Introduction
4. Market Overview
5. Bispecific Antibody Therapeutics: Technology Platforms
6. Drug Profiles
7. Key Insights
8. Benchmark Analysis: Big Pharma Players
9. Partnerships and Collaborations
10. Contract Services for Bispecific Antibody Therapeutics
11. Clinical Trial Analysis
12. Case Study: Regulatory Guidelines for Bispecific Antibodies
13. Case Study: Promotional / Marketing Strategies
14. SWOT Analysis
15. Market Forecast and Opportunity Analysis
16. Concluding Remarks
17. Executive Insights
18. Appendix 1: Tabulated Data
19. Appendix 2: List of Companies and Organizations
To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/bispecific-antibodies/286.html
Contact Details
Gaurav Chaudhary
+1 (415) 800 3415
gaurav.chaudhary@rootsanalysis.com
Add Comment
General Articles
1. Enhancing Your Online Presence: The Synergy Of Website Design And Seo PackagesAuthor: Shaganasaral
2. Why Invest In An Uber Clone App For Your Startup
Author: Smith Joe
3. Unleashing The Power Of White Label Crypto Exchange Software For Startups
Author: white label
4. Buy Led Light Therapy For Skin For Radiant And Healthy Skin
Author: Zuzusales LLC
5. Hip Kits And Dining Aids – Improving The Quality Of Life Everyday
Author: Zuzusales LLC
6. 30w 24v Solidrive Electronic Non-dimmable Constant Voltage Driver By Magnitude
Author: David Hessen
7. Navigating Your Journey With Pratham Motors: Maruti Suzuki Driving School In Hsr Layout
Author: Pratham Motors
8. Best Accounting Software For Petrol Pump
Author: sidharthh08877
9. How To Create An Arbitrum Crypto Wallet & Evaluate Its Cost
Author: JohnJames
10. Can An Exchange Traded Fund Give You Good Returns Over The Long Term?
Author: SURAAJ
11. How Should You Plan For Your Retirement?
Author: SURAAJ
12. Harnessing Biological Odour Control Systems For Electronics Corrosion Monitoring
Author: Aqozz
13. Induce More Happiness By Not Searching How To Remove Glance From Lock Screen In Mi!
Author: Jaykant P
14. Choosing The Right Statistical Consultancy Services Africa For Better Results
Author: Stat Consul
15. Global Bottled Water Processing Market: Key Trends And Insights By 2028
Author: sonal